Trigger Point Pain, Myofascial
Conditions
Keywords
Latent trigger point, Dry needling, Myotonometer, Tensiomyography
Brief summary
The purpose of this study is to determine whether application of Dry Needling (DN) is effective for improved Muscle Mechanical Properties and Muscle Contractility in Latent Trigger Points point (LTrP) of upper trapezius. Randomized controlled trial, in parallel with cross-control design. Two groups with LTrP in upper trapezius, and will be randomly selected to DN group or Sham-Dn group.
Interventions
Deep Dry Needling into the site of the latent Trigger Point of the upper trapezius muscle. 1 session in upper trapezius muscle moving the needle up and down ten times.
DEVICEControl-Dry Needling
Sham Dry Needling into the site of the latent Trigger Point of the upper trapezius muscle with non-penetrating needles
Sponsors
University of Castilla-La Mancha
Study design
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
DOUBLE (Subject, Outcomes Assessor)
Eligibility
Sex/Gender
ALL
Age
18 Years to 30 Years
Healthy volunteers
Yes
Inclusion criteria
* Age between 18 and 30 years * The presence of LTrP in the middle third of the upper trapezius muscle on the dominant side * Being able to provide written informed consent * Being able to follow instructions and realize clinical tests
Exclusion criteria
* Any pharmacological therapeutic * Any medical treatment or physical therapies at cervical region during the 6-month before this study - Any diagnosed health problem * Any history of head and upper extremity surgery or trauma * Any red flags to DN, (ie: metabolic diseases, pregnancy, kinesiophobia, Infection, cancer) * Absence of recurrent history of neck pain * No neck pain symptomatology the previous 6 months * Cervical disk herniation
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Change in Stiffness | Baseline, at 30 minutes after treatment, at 24 hours after treatment, at 72 hours after treatment | This outcome measure is obtained by a device named MyotonPro. Stiffness reflects the resistance of the muscle to the force deforming the muscle. |
| Change in Maximal Radial Displacement (Dm) | Baseline, at 30 minutes after treatment, at 24 hours after treatment, at 72 hours after treatment | This outcome measure is obtained by a device named Tensiomiography. The variable Dm is given by the radial displacement of the muscular belly in a transverse plane, expressed in millimeters (mm) and depends on muscle tone or stiffness. A low Dm is related to a high muscle tone or an excess of stiffness, while a high Dm value indicates a lack of muscle tone or stiffness defect. |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Change in Mechanical Stress Relaxation Time [ms] | Baseline, at 30 minutes after treatment, at 24 hours after treatment, at 72 hours after treatment | This outcome measure is obtained by a device named MyotonPro. Mechanical Stress Relaxation Time \[ms\] is the time for a muscle to recover tis shape from deformation after a voluntary contraction or a removal of an external force. |
| Change in Ratio of deformation and Relaxation time, characterising Creep (Deborah number) | Baseline, at 30 minutes after treatment, at 24 hours after treatment, at 72 hours after treatment | This outcome measure is obtained by a device named MyotonPro. Ratio of deformation and Relaxation time, characterising Creep (Deborah number) is the gradual elongation of a tissue over time when placed under a constant tensile stress. |
| Change in Contraction time (Tc) | Baseline, at 30 minutes after treatment, at 24 hours after treatment, at 72 hours after treatment | This outcome measure is obtained by a device named Tensiomiography. Contraction time (Tc) as a time between 10% and 90% of the contraction |
| Change in Oscillation Frequency | Baseline, at 30 minutes after treatment, at 24 hours after treatment, at 72 hours after treatment | This outcome measure is obtained by a device named MyotonPro. The frequency of the damped oscillations characterizes the muscle tone. |
| Change in Sustain time (Ts) | Baseline, at 30 minutes after treatment, at 24 hours after treatment, at 72 hours after treatment | This outcome measure is obtained by a device named Tensiomiography. Sustain time (Ts) as a time between 50% of the contraction and 50% of the relaxation |
| Change in Relaxation time (Tr) | Baseline, at 30 minutes after treatment, at 24 hours after treatment, at 72 hours after treatment | This outcome measure is obtained by a device named Tensiomiography. Relaxation time (Tr) as a time between 90% and 50% of the relaxation |
| Change in Pressure Pain Perception (PPP) | Baseline, at 30 minutes after treatment, at 24 hours after treatment, at 72 hours after treatment | Change in Pain Pressure Threshold (PPT) as assessed using an manual mechanical algometer. The procedure performed was the same as the prior described, but pressure was kept until 2.5 kg/cm2 and maintained for 5 seconds, whereas the subject had to characterize the level of pain using a 10-mm visual analog scale (VAS) |
| Change in Delay time (Td) | Baseline, at 30 minutes after treatment, at 24 hours after treatment, at 72 hours after treatment | This outcome measure is obtained by a device named Tensiomiography. Delay time (Td) as a time between the electrical impulse and 10% of the contraction |
| Change in Decrement (elasticity) | Baseline, at 30 minutes after treatment, at 24 hours after treatment, at 72 hours after treatment | This outcome measure is obtained by a device named MyotonPro.The logarithmic decrement of the damping oscillations characterizes muscle elasticity which is the ability of the muscle to restore its initial shape after contraction |
Countries
Spain
Outcome results
None listed